Daniel Van Plew
2017
In 2017, Daniel Van Plew earned a total compensation of $9M as Executive Vice President and General Manager, Industrial Operations and Product Supply at Regeneron Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $524,160 |
|---|---|
| Option Awards | $7,875,030 |
| Salary | $560,000 |
| Other | $19,410 |
| Total | $8,978,600 |
Van Plew received $7.9M in option awards, accounting for 88% of the total pay in 2017.
Van Plew also received $524.2K in non-equity incentive plan, $560K in salary and $19.4K in other compensation.
Rankings
In 2017, Daniel Van Plew's compensation ranked 760th out of 14,666 executives tracked by ExecPay. In other words, Van Plew earned more than 94.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 760 out of 14,666 | 95th |
Division Manufacturing | 252 out of 5,770 | 96th |
Major group Chemicals And Allied Products | 61 out of 2,074 | 97th |
Industry group Drugs | 42 out of 1,730 | 98th |
Industry Pharmaceutical Preparations | 35 out of 1,329 | 97th |
Source: SEC filing on April 26, 2019.
Van Plew's colleagues
We found three more compensation records of executives who worked with Daniel Van Plew at Regeneron Pharmaceuticals in 2017.
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019